Isoniazid and rifampicin exposure during treatment in drug-susceptible TB. Akkerman OW, Dijkwel RDC, Kerstjens HAM, van der Werf TS, et al. Int J Tuberc Lung Dis 2023;27:772-777.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Akkerman OW, Dijkwel RDC, Kerstjens HAM, van der Werf TS, et al. Isoniazid and rifampicin exposure during treatment in drug-susceptible TB. Int J Tuberc Lung Dis 2023;27:772-777.
PMID: 37749836